506197 Stock Overview
Develops, manufactures, and markets pharmaceutical formulations in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Bliss GVS Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹118.65 |
| 52 Week High | ₹148.95 |
| 52 Week Low | ₹77.65 |
| Beta | 1.04 |
| 11 Month Change | 15.42% |
| 3 Month Change | -3.22% |
| 1 Year Change | 18.48% |
| 33 Year Change | 10.27% |
| 5 Year Change | 26.63% |
| Change since IPO | 46,527.42% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506197 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 7.7% | 2.2% | -1.0% |
| 1Y | 18.5% | 46.7% | 43.6% |
Return vs Industry: 506197 underperformed the Indian Pharmaceuticals industry which returned 46.7% over the past year.
Return vs Market: 506197 underperformed the Indian Market which returned 43.6% over the past year.
Price Volatility
| 506197 volatility | |
|---|---|
| 506197 Average Weekly Movement | 5.8% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.7% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 506197 has not had significant price volatility in the past 3 months.
Volatility Over Time: 506197's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 831 | Gagan Sharma | www.blissgvs.com |
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, soaps, sprays, and vaginal washes.
Bliss GVS Pharma Limited Fundamentals Summary
| 506197 fundamental statistics | |
|---|---|
| Market cap | ₹12.44b |
| Earnings (TTM) | ₹814.66m |
| Revenue (TTM) | ₹7.94b |
15.3x
P/E Ratio1.6x
P/S RatioIs 506197 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506197 income statement (TTM) | |
|---|---|
| Revenue | ₹7.94b |
| Cost of Revenue | ₹4.01b |
| Gross Profit | ₹3.93b |
| Other Expenses | ₹3.11b |
| Earnings | ₹814.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.77 |
| Gross Margin | 49.47% |
| Net Profit Margin | 10.26% |
| Debt/Equity Ratio | 10.0% |
How did 506197 perform over the long term?
See historical performance and comparison